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Abstract
Background: Rhinitis can cause a heavy toll on patients because of its bothersome effects on
productivity. This retrospective study was conducted to explore the clinical profile, outcomes and
improvement in the symptoms and productivity resulting from treatment of allergic rhinitis in
Pakistan.
Methods: We carried out a retrospective file review of all allergic rhinitis patients who presented
to the Ear, Nose, Throat Consulting Clinic from January, 2006 to June, 2008 using a structured
proforma especially designed for this purpose. Data was entered and analyzed using SPSS v. 16.0.
Results: The charts of 169 patients were reviewed. The mean age of the patients was 35.2 ± 9.1
years. Sixty percent patients were male. Ninety eight patients (58%) reported allergy symptoms to
be present at both home and work. One hundred and two patients (60.4%) had symptoms severe
enough to cause absence from work or academic activities. Up to seventy one percent patients
were spending between 1000 - 3000 Pakistani Rupees (1 US$= 83.3 Pakistani rupees) on the
treatment of allergic rhinitis per year. One hundred and fifty one patients (89.3%) reported an
improvement in rhinitic symptoms and productivity while 18 patients (10.7%) didn't. This
improvement was significantly associated with satisfaction with treatment (p < 0.001).
Conclusion: Allergic rhinitis, a ubiquitous disease, was seen to cause a strain on patients in the
form of recurrent treatment-related expenses as well as absenteeism from work or other daily
activities. Symptoms and productivity improved significantly after treatment.
Background
Allergic rhinitis (AR) is characterized by the inflammation
of the nasal mucosa. It is induced by exposure to allergens
that trigger an immunoglobulin E (IgE) mediated inflam-
matory response that can result in chronic or recurrent
symptoms of rhinorrhea, congestion, and sneezing. The
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condition can be seasonal or chronic and originates from
airborne agents such as pollens, mold spores, and dust-
borne mites [1-5].
AR represents a global health issue affecting 10% to 25%
of the world population. The increasing prevalence of this
condition has resulted in a significant impact on the Qual-
ity of Life (QOL) in addition to imposing a considerable
socio-economic burden on patients [6,7]. AR is a major
chronic respiratory disease by virtue of its high prevalence
and significant effect on, work or school performance,
and productivity [5]. It also makes asthma control a diffi-
cult task for patients and their clinicians and is one of the
ten leading reasons for seeking primary health care [1,8].
The determinants of QOL in AR are imperfectly under-
stood at best. More specifically, the influence of socio-
demographic factors on QOL in patients with allergic
rhinitis has been little investigated so far. In a study done
in France, it was reported that residence in the country-
side, female gender and a lower education level were inde-
pendent predictors of poorer QOL in AR patients [9].
Moreover, most of the current literature on allergic rhini-
tis has focused on developed countries whereas research
from developing countries on the subject is not ade-
quately represented.
Improvement in symptoms and productivity in patients
with AR has an important relationship with a multitude of
clinical, immunological, and functional parameters
[9,10]. AR represents a debilitating drain on the health,
financial and other resources in the form of multiple
clinic visits and multiple days lost from work or school.
All of these parameters compositely translate into
impeded productivity for a developing country like Paki-
stan where health care is already plagued by issues of
affordability and accessibility. Limited literature is availa-
ble regarding the management and subsequent improve-
ment in symptoms and productivity after treatment of AR
in Pakistan. Our study, therefore, serves as an important
document to fill the gaps in information with respect to
the local perspective. We aimed to describe the socio-
demographic characteristics of patients with AR and to
assess the improvement in symptoms and productivity
after administration of therapy.
Methods
Study design and setting
We carried out a retrospective file review of all AR patients
who presented to a single faculty member at the Aga Khan
University Hospital (AKUH) Ear Nose Throat (ENT) Con-
sulting Clinic from January, 2006 to June, 2008.
Inclusion and exclusion criteria
All patients older than 10 years of age and with a clinical
diagnosis of AR were selected for this study. AR was diag-
nosed based on a thorough history and a complete clini-
cal examination by a single faculty member to ensure
uniformity in diagnosis. By using this comprehensive clin-
ical approach, patients with AR were diagnosed and dis-
tinguished from patients affected by vasomotor,
infectious or other inflammatory rhinitis. Similarly,
patients with other nasosinusal anomalies presenting
with rhinitic symptoms were excluded on the basis of his-
tory and physical examination. Patients with associated
surgical pathology such as deviated nasal septum (DNS),
hypertrophic turbinates or nasal polyposis were sched-
uled for appropriate surgical procedure and excluded
from this retrospective review. Unfortunately, skin testing
and specific IgE testing against allergens was not per-
formed because of financial restraints cited by most of the
patients attending the clinic. The cost of IgE antibody is
PKRs. 1,050 while skin allergy testing costs around PKRs.
1,500. According to recent financial reports, the per capita
income in Pakistan has grown over the past few years [11]
but is very closely paralleled by increases in inflation, and
conducting expensive tests in this clinical arena may not
be a financially feasible option for many patients.
Ethical considerations
The protocol of this study was submitted to the Ethical
Review Committee (ERC) at AKUH. Being a retrospective
study, the protocol was granted exemption from review as
per guidelines of the ERC. Informed consent was not
needed owing to the anonymous presentation of the
patient data as per guidelines of the ERC at AKUH.
Management Regime
The type of drug prescribed to the patients for the treat-
ment of AR was random; some patients received more
than one medication. Patients were also counseled about
the non-pharmacological treatment measures for AR such
as steam inhalation and lifestyle changes to avoid expo-
sure to allergens. The mean duration of therapy was 3
months.
Improvement in symptoms and productivity
A standardized tool for measuring QOL was not used
because of two primary reasons:
a) Firstly, this was a retrospective chart review whereby a
QOL measuring tool could not be administered at base-
line and terminus of treatment.
b) Secondly, the use of QOL tools in a high volume, busy
ENT clinic in a developing country is a highly arduous
task in actual clinical practice.
Measurement of improvement in quality of life of patients
was therefore simplified for all practical purposes and
assessed using a composite score based on variables such
as reduction of complaints after institution of treatment asBMC Ear, Nose and Throat Disorders 2009, 9:12 http://www.biomedcentral.com/1472-6815/9/12
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well as reduction in absenteeism from work or other daily
activities such as school/college. Patients were asked
about improvement in symptoms and productivity at the
end of treatment and this was documented in the patient's
charts. Patients reporting more than 50% improvement
across the variables of symptoms and productivity as com-
pared to their baseline situation were categorized as hav-
ing an improvement.
Data collection, management and statistical analysis
The data was collected on a pre-tested, structured pro-
forma especially prepared for the purpose. The data pro-
cured from the file review were coded and entered in SPSS
version 16.0 for analysis. In descriptive analysis, the mean
and standard deviation of continuous variables and per-
centages of categorical variables were computed. Associa-
tions were evaluated using chi-square test and Fisher's
exact test where applicable. A p-value of < 0.05 was con-
sidered statistically significant, unless otherwise specified.
Results
A total of 169 files were reviewed in accordance with the
inclusion criteria used in our study.
Socio-demographic data
The mean age of the patients was 35.2 ± 9.1 years. One
hundred and two patients (60.4%) were male while 67
(39.6%) were female. Most of the patients in the sample
were well educated. The nature of the job was primarily
office work in 83 patients (49.1%) and primarily field
work in 20 patients (11.8%).
Variables related to allergic rhinitis
The allergens were reported as being household by 120
patients (71%), environmental by 137 patients (81.1%),
insect-related by 1 patient (0.6%), animal-related by 13
patients (7.7%) and occurring at place of work by 10
patients (5.9%). Ninety eight patients (58%) reported
allergy symptoms to be present at both home and work,
29 patients (17.2%) reported allergy symptoms to be
present at work only while 42 patients (24.8%) reported
the allergy symptoms to be present at home only. Most of
the patients (24.3%) reported a daily exposure time to
allergens between 6 to 8 hours; this was based on patient
perception of symptoms and allergens. Baseline features
of our sample have been shown in table 1. Sneezing
(79.9%), watery rhinorrhea (76.9%) and nasal conges-
tion (75.7%) were the most common complaints of the
patients at the time of presentation to the ENT Consulting
Clinic. In addition, many patients reported ocular com-
plaints (43.8%) and post nasal drip (55%) as well. Addi-
tional systemic complaints reported by patients included
generalized weakness (79.9%), fatigue (76.9%), difficulty
in concentrating (48.5%), irritability (46.2%) and
decreased sleep at night (38.5%). Change in climate
(89.3%) and exposure to various odors (77.5%) were
reported as the most common triggering factors for symp-
toms by the patients.
Social and financial impact of symptoms
One hundred and two patients (60.4%) had symptoms
severe enough to cause absence from work. Eighty nine
patients (87.2%) reported at least 1 - 2 days of absence
from work while the remaining 13 patients (12.8%)
reported missing from 3 to 8 days of work; this absentee-
ism occurred in association with the presence of symp-
toms. Up to seventy one percent patients were spending
between 1000 - 3000 Pakistani Rupees on the treatment
of AR per year in the form of consultation fees and medi-
cations costs. Twenty nine patients (17.2%) were spend-
ing between 100 - 1000 Rupees while 20 patients (11.8%)
were spending more than 3000 Rupees on treatment of
AR.
Treatment of allergic rhinitis
Seventy six patients (45%) were not using any medication
before consulting the ENT specialist at AKUH. The
remaining patients were either using antihistamines [58
(34.3%)], steroids [9 (5.3%)], analgesics [40 (23.7%)] or
antibiotics [24 (14.2%)]. Antihistamines (95.3%) and
steroids (79.9%) were the most commonly prescribed
medications for the treatment of AR at our institute. In
addition, leukotriene receptor antagonist was also pre-
scribed to 69 (40.8%) patients. Less commonly prescribed
medications were anticholinergic agents [11 (6.5%)] and
sympathomimetic decongestants [57 (33.7%)]. Table 2
shows the trigger for symptoms and the frequency of
absence from work in patients with AR.
Improvement in symptoms and productivity
On the whole, 151 patients (89.3%) reported an improve-
ment in their symptoms and productivity while 18
patients (10.7%) didn't. The associations between this
improvement and various factors have been shown in
table 3. One forty nine patients (88.2%) had reported sat-
isfaction with their treatment while the remaining 20
patients (11.8%) were not satisfied with their treatment.
Improvement in symptoms and productivity was signifi-
cantly associated with satisfaction with treatment (p <
0.001).
Discussion
Although considered a relatively benign condition, AR
can exact a heavy toll on patients by virtue of its high prev-
alence and significant effect on work or school perform-
ance and productivity.
Although AR is more often seen in children, the age of
diagnosis can be quite variable, as it was diagnosed even
in the geriatric age group as seen in our study. PreciselyBMC Ear, Nose and Throat Disorders 2009, 9:12 http://www.biomedcentral.com/1472-6815/9/12
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Table 1: Baseline characteristics of patients with allergic rhinitis
Baseline variables of patients with allergic rhinitis Frequency (%)
(n = 169)
Age in years
10-20 15 (8.9)
21-30 39 (23.1)
31-40 60 (35.5)
41-50 46 (27.2)
51-60 7 (4.1)
61-70 2 (1.2)
Gender
Male 102 (60.4)
Female 67 (39.6)
Education
Primary (till grade 5) 5 (3)
Secondary (till grade 10) 12 (7.1)
Higher secondary (till grade 12) 35 (20.7)
Graduation/post-graduation 117 (69.2)
Nature of job
Office work 83 (49.1)
Field work 20 (11.8)
Both types of work 15 (8.9)
Neither type of work 51 (30.2)
History of any known allergies 165 (97.6)
Family history of allergies 129 (76.3)
Place where allergy symptoms are present
Home 42 (24.8)
Work 29 (17.2)
Both 98 (58)BMC Ear, Nose and Throat Disorders 2009, 9:12 http://www.biomedcentral.com/1472-6815/9/12
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consistent epidemiologic data regarding AR are generally
difficult to obtain because various studies have used dif-
ferent definitions of AR. We encountered patients aged 10
years and above in the ENT clinic at our institution. The
mean age of diagnosis in our patients was, however, 35.2
years. This is in concordance with another study group
that evaluated patients of AR; the mean age of diagnosis
being 32 years [12].
In our study, more than half of the patients (69.2%) were
educated at least till their graduation or post-graduation.
Patients who are better educated are more likely to under-
stand the pathophysiological basis of AR and hence the
importance of treatment, avoidance of allergens and pre-
vention of episodes of disease. It has already been proven
that lower level of education is an independent predictor
of a poorer quality of life in patients with AR [9]. How-
ever, we did not find a statistically significant association
between the education level and improvement in symp-
toms and productivity in our patients, probably because
of the high baseline education level of the majority of the
patients.
We found a slight male predominance in our patients,
which is in agreement with other studies reported in liter-
ature [6,13]. A French study reported that despite male
predominance in the prevalence of AR, the female gender
is more strongly associated with a poorer QOL [9]. In our
study, a significant association between gender and
improvement in symptoms and productivity was not
seen. We were expecting to see a significant association
because of the differential nature of exposure and time of
exposure. Females in our regions mostly spend time
indoors as compared to their male counterparts and
would therefore be exposed to different allergens
An earlier study investigated the types of allergens associ-
ated with AR via allergy testing and found that the per-
Exposure time to allergens in 24 hours (in hours)
0-2 32 (18.9)
> 2-4 18 (10.7)
> 4-6 36 (21.3)
> 6-8 41 (24.3)
> 8-12 31 (18.3)
> 12 2 (1.2)
All the time 9 (5.3)
Table 1: Baseline characteristics of patients with allergic rhinitis (Continued)
Table 2: Trigger for symptoms and absence from work in 
patients with Allergic Rhinitis
Variables of patients with allergic rhinitis Frequency (%) *
Triggers for symptoms (n = 169)
Change in climate 151 (89.3)
Odors ** 131 (77.5)
Hot or spicy food 10 (5.9)
Emotional changes 28 (16.6)
Environmental factors^ 43 (25.4)
None of the above 7 (4.1)
Frequency of absence from work (n = 102)
Every 1 month 16 (15.7)
Every 2 months 35 (34.3)
Every 3 months 33 (32.3)
Every 4 months 13 (12.7)
Every 5 months 2 (2)
Every 6 months 1 (1)
More than 6 months 2 (2)
* Some percentages don't add upto 100% because of multiple 
response questions
** Perfumes, cigarette smoke, paint fumes and ink
^Barometric changes, bright lightsBMC Ear, Nose and Throat Disorders 2009, 9:12 http://www.biomedcentral.com/1472-6815/9/12
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Table 3: Associations between the improvement in symptoms and productivity and different variables
Variables affecting symptoms and productivity of patients Improvement (f)
Yes No
Age in years (p = 0.87)
≤20 14 1
21-40 88 11
> 40 49 6
Gender (p = 0.57)
Male 91 11
Female 60 7
Education (p = 0.54)
Primary (till grade 5) 50
Secondary (till grade 10) 11 1
Higher secondary (till grade 12) 33 2
Graduation/post-graduation 102 15
Exposure time to allergen in 24 hours (in hours) (p = 0.24)
≤2 29 3
> 2-6 51 3
> 6 71 12
Type of medication prescribed
Steroids (oral/nasal) (p = 0.49) 120 15
Antihistamines (p = 0.60) 144 17
Sympathomimetic decongestants (p = 0.84) 50 7
Anticholinergics (0.67) 10 1
Leukotriene receptor antagonists (p = 0.54) 62 7
Duration for which medication was used (in months) (p = 0.94)
≤1 36 5
> 1-3 95 10
> 3-6 18 3
> 6-12 10
> 12 10BMC Ear, Nose and Throat Disorders 2009, 9:12 http://www.biomedcentral.com/1472-6815/9/12
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centages of positive reactions to grass, tree, and herb
pollens were equally high (30 - 40%). Sensitivity to house
dust was present in 44% of the patients but the heteroge-
neous composition of house dust made it difficult to
determine the exact allergenic factors. Animal danders
were not found to be of great importance [14]. In contrast,
a recent Chinese study has demonstrated that dermatoph-
moides (47%), herbs (19.7%), tree (18%), animal dander
(8.9%) and house dust (6.5%) are important allergens in
patients with AR in this order of frequency [15]. In
another recent study from the Mersin region, mites and
pollen were found to be the most common allergens in
patients with AR. This study also concluded that the distri-
bution of allergens in patients with AR is associated with
climatic, environmental and socioeconomic factors of the
area [16]. Other studies from Konya region and China
have shown a similar distribution of allergens [17,18].
In our study, most of the patients reported symptoms in
both the indoor and outdoor environments, which sug-
gests that patients were sensitized to various allergens at
the same time and the cumulative effect of these expo-
sures was more as compared to isolated exposures. Most
of the patients reported a daily exposure time of allergens
to be between 6 and 8 hours.
The most common symptoms that were reported by the
patients in our study were sneezing, watery rhinorrhea
and nasal congestion, which were present in more than
half of the patients, but other complaints like post nasal
drip, ocular symptoms, itching, cough, sore throat,
hoarseness and even decreased sense of taste were also
reported. A number of triggers for these symptoms were
mentioned by the patients, of which change in climate
and odors like perfumes, cigarette smoke, paint fumes and
ink, were the main triggers responsible for producing the
symptoms. Documentation of these triggers and their sub-
sequent prevention is therefore an important part of
patient education and clinicians should be cognizant of
this aspect of patient care and disease management.
High incidence of allergic rhinitis, combined with the
cold- and flu-like symptoms, may cause absenteeism or
reduced productivity while at work when the condition is
untreated. In 60.4% of our patients, the symptoms were
severe enough to cause absenteeism from work. On fur-
ther questioning, most patients answered that they missed
on average 1-2 days because of their symptoms. Most of
these episodes used to occur with a frequency of once
every two to three months. Further, many over-the-coun-
ter (OTC) treatments for allergic rhinitis have sedative
side effects associated with reduction in productivity.
Numerous studies have demonstrated a relationship
between antihistamine use and subsequent effects on
sedation, psychomotor performance, and cognition [19-
21]. Hence, the chronic nature of rhinitis, its high preva-
lence, adverse effects on QOL, and the use of known effec-
tive treatments make this a likely target for quality
improvement programs [5].
Generally, employers do not consider the potential for
productivity losses due to allergic rhinitis to be a major
concern. These productivity losses and associated costs
may, however, be substantial. Cost issues must be
Regularity in use of medication (p = 0.18)
Yes 133 14
No 18 4
Non-pharmacological advice given to patient (p = 0.71)
Yes 148 18
No 30
Compliance of patient in following the advice about lifestyle changes (p = 0.12)
Yes 142 15
No 93
Satisfaction with treatment (p < 0.001)
Yes 139 10
No 12 8
Table 3: Associations between the improvement in symptoms and productivity and different variables (Continued)BMC Ear, Nose and Throat Disorders 2009, 9:12 http://www.biomedcentral.com/1472-6815/9/12
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addressed in the management as cost-effective manage-
ment is fundamental in the proper care of allergic rhinitis.
The total cost of allergic rhinitis in the United States was
estimated at $7.9 billion in 1997, including $4.5 billion
in direct medical costs and an additional $3.4 billion in
indirect costs, mostly related to reduced work productiv-
ity. AR is responsible for 3.8 million days lost each year
from work and school in the United States [3]. In our
study, most people reported an expenditure of between
Rs. 1000 to Rs. 3000 per annum on medications and con-
sultations regarding their episodes of AR. There are other
important aspects in caring for patients with allergic rhin-
itis that are equally important in achieving the best out-
comes for sufferers of allergic rhinitis. Compliance is
essential in getting optimal medical management. Issues
such as failure to take and improper use of medications as
prescribed can lead to dissatisfaction in controlling symp-
toms in one study [22].
In our study, the patients had been prescribed various
medications for the treatment of AR. Most common med-
ication used was anti-histamines, followed by analgesics,
antibiotics and steroids. Leukotriene receptor antagonist
was also prescribed to some patients. According to our
results, none of the medications used seemed to have a
significant role in improvement of symptoms and produc-
tivity in these patients in comparison to each other. There
are two reasons to explain this finding. It could be because
many patients were receiving more than one medication
at a time; hence the confounding effect of one medication
on the effect of the other can't be eliminated. Therefore, it
is difficult to comment on which drug exactly had the
greatest impact. The retrospective design of the study is
also an important consideration in this regard. Secondly,
the compliance was measured only in terms of documen-
tation based on subjective parameters, patient statements
and recall. Although antihistamines provide temporary
relief, studies have shown that intranasal corticosteroids
are the most effective medication for reducing congestion
in patients with inflammatory nasal conditions [23].
The improvement in symptoms and productivity was sig-
nificantly associated with satisfaction with treatment (p <
0.001). As mentioned earlier, AR is a condition that signif-
icantly impairs the productivity of patients. Improvement
in such productivity is one of the primary goals of treat-
ment of this condition and achievement of this goal
imparts the patients with a sense of satisfaction from the
treatment administered by their physician as was seen in
our study.
Strengths and limitations
This study provides an important perspective regarding
the management and outcome of allergic rhinitis from a
developing country. However, we would also like to
acknowledge the following limitations of this study. Our
diagnosis of AR was "sign and symptom" based; this
approach was undertaken because of the financial con-
straints cited by majority of patients who could not afford
expensive testing such as skin tests and IgE testing against
specific allergens. Also, these tests are not ubiquitously
available in Pakistani hospitals. Hence, by using a com-
prehensive clinical approach, patients with AR were dis-
tinguished from patients affected by vasomotor,
infectious or other inflammatory rhinitis.
Because of its retrospective nature, a standardized tool for
measuring QOL could not be used for this study. There-
fore, we used a simplified measure of improvement in
terms of symptoms and productivity. This approach
appears more practical for a high volume clinic in a devel-
oping country like Pakistan where administration of
multi-item QOL questionnaires may not be feasible.
Another shortcoming that should be pointed out is the
considerable subjectivity involved in measuring the daily
exposure time to allergens. This was based on patient's
perception and recall of symptoms occurring in that par-
ticular setting over a considerable length of time on most
days to any known or likely allergen.
Conclusion
Allergic rhinitis, a ubiquitous disease, has a significant
impact on patients because of bothersome symptoms and
expenses incurred from treatment as was seen in our
study. Current therapy is effective in improving the qual-
ity of life in these patients. Current literature on allergic
rhinitis from the developing world is lacking and under-
represented. Therefore, this study is an important baseline
document. The results obtained from our study can help
improve outcomes by improving prescribing practices.
We acknowledge the limitations of this study, particularly
its retrospective design. Prospective studies with more
robust designs are needed in our region to correctly docu-
ment the burden of the disease, to engineer strategies
whereby the improvement in symptoms and productivity
of patients with AR can be maximized, and to collate the
significant findings observed in our study.
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